Lymphoma Diagnosis and Plasma Epstein-Barr Virus Load during Vicriviroc Therapy: Results of the AIDS Clinical Trials Group A5211

BACKGROUND: Lack of functional CCR5 increases the severity of certain viral infections, including West Nile virus and tickborne encephalitis. In a phase II trial of the investigational CCR5 antagonist vicriviroc (AIDS Clinical Trials Group protocol A5211), 4 lymphomas occurred in study patients who...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Tsibris, Athe M. N., Paredes, Roger, Chadburn, Amy, Su, Zhaohui, Henrich, Timothy J., Krambrink, Amy, Hughes, Michael D., Aberg, Judith A., Currier, Judith S., Tashima, Karen, Godfrey, Catherine, Greaves, Wayne, Flexner, Charles, Skolnik, Paul R., Wilkin, Timothy J., Gulick, Roy M., Kuritzkes, Daniel R.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2009
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2756462/
https://ncbi.nlm.nih.gov/pubmed/19191652
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/597007
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge